Literature DB >> 1314769

Non-A, non-B chronic hepatitis is chronic hepatitis C: a sensitive assay for detection of hepatitis C virus RNA in the liver.

K Hosoda1, M Omata, O Yokosuka, N Kato, M Ohto.   

Abstract

To study the role of hepatitis C virus in non-A, non-B chronic hepatitis, 49 liver biopsy samples from 40 patients with non-A, non-B chronic hepatitis and 9 control patients were analyzed by complementary DNA/polymerase chain reaction. Two segments of the HCV genome, one in the nonstructural region and the other in the noncoding region, were amplified by two sets of primer pairs. With use of the nonstructural region primers, hepatitis C virus RNA was detected in 24 (60%) of 40 patients with non-A, non-B chronic hepatitis. Of these 40 patients, RNA was detected in 19 (70%) of 27 patients positive for antibody to hepatitis C virus and in 5 (38%) of 13 patients negative for antibody to hepatitis C virus. However, with the noncoding region primers, hepatitis C virus RNA was detected in 38 (95%) of 40 patients with non-A, non-B chronic hepatitis. Of these patients, the RNA was detected in 26 (96%) of 27 patients positive for antibody to hepatitis C virus and also in 12 (92%) of 13 patients positive for antibody to hepatitis C virus. Hepatitis C virus RNA was not detected in any of the control patients. Sequence analysis showed homology between our samples and the prototype to be only 66% to 77% in the nonstructural region but 99% to 100% in the noncoding region. We conclude that almost all patients with non-A, non-B chronic hepatitis in Japan are currently infected with hepatitis C virus, regardless of the presence or absence of antibody to hepatitis C virus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314769     DOI: 10.1002/hep.1840150506

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Clinician's guide to diagnostic tests for hepatitis C virus infections.

Authors:  G Delage
Journal:  Can J Infect Dis       Date:  1993-05

2.  Detection and typing of hepatitis C RNA in liver biopsies and its relation to histopathology.

Authors:  G Cathomas; C E McGandy; L M Terracciano; F Gudat; L Bianchi
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

3.  Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.

Authors:  J M Sánchez-Tapias; X Forns; S Ampurdanés; L Titó; R Planas; J M Viver; D Acero; M Torres; P Mas; R Morillas; M Forné; J Espinós; J M Llovet; J Costa; E Olmedo; F X López-Labrador; M T Jiménez de Anta; J Rodés
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system.

Authors:  A Nishizono; M Hiraga; K Mifune; H Terao; T Fujioka; M Nasu; T Goto; J Misumi; M Moriyama; Y Arakawa
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  HCV infection in patients with primary defects of immunoglobulin production.

Authors:  I Quinti; F Pandolfi; R Paganelli; D el Salman; A Giovannetti; R Rosso; A Oliva; L Rainaldi; F Aiuti
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  HCV infection in Egyptian patients with acute hepatitis.

Authors:  I Quinti; D el-Salman; M K Monier; B G Hackbart; M S Darwish; D el-Zamiaty; R Paganelli; F Pandolfi; R R Arthur
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

7.  Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon.

Authors:  G E Kleter; J T Brouwer; R A Heijtink; S W Schalm; W G Quint
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 8.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

9.  Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C.

Authors:  K Moriya; K Yasuda; K Koike; Y Ichinose; H Yotsuyanagi; K Kurokawa; S Iino
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.